Heart-After-Liver Transplantation Attenuates Rejection of Cardiac Allografts in Sensitized Patients.
暂无分享,去创建一个
A. Behfar | J. Heimbach | R. Rodeheffer | S. Dunlay | S. Kushwaha | J. Dearani | N. Pereira | M. Gandhi | R. Frantz | R. Daly | C. Rosen | A. Clavell | B. Edwards | A. Rosenbaum | B. Boilson | J. Schirger | T. Taner
[1] Y. Woo,et al. Short‐term outcomes of en bloc combined heart and liver transplantation in the failing Fontan , 2019, Clinical transplantation.
[2] J. Kobashigawa,et al. Sensitization in Heart Transplantation: Emerging Knowledge: A Scientific Statement From the American Heart Association. , 2019, Circulation.
[3] J. Wetzels,et al. Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab , 2019, Clinical Pharmacokinetics.
[4] M. Stegall,et al. Donor-specific hypo-responsiveness occurs in simultaneous liver-kidney transplant recipients after the first year. , 2018, Kidney international.
[5] L. Potena,et al. The management of antibodies in heart transplantation: An ISHLT consensus document. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[6] M. Stegall,et al. Unique molecular changes in kidney allografts after simultaneous liver-kidney compared with solitary kidney transplantation. , 2017, Kidney international.
[7] D. Mancini,et al. Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[8] K. Mandal,et al. The Paradoxical Relationship Between Donor Distance and Survival After Heart Transplantation. , 2017, The Annals of thoracic surgery.
[9] J. Kobashigawa,et al. Calculated panel-reactive antibody predicts outcomes on the heart transplant waiting list. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[10] M. Stegall,et al. Liver Allograft Provides Immunoprotection for the Cardiac Allograft in Combined Heart–Liver Transplantation , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[11] J. Patel,et al. Desensitization strategies in adult heart transplantation-Will persistence pay off? , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[12] M. Stegall,et al. Decreased chronic cellular and antibody-mediated injury in the kidney following simultaneous liver-kidney transplantation. , 2016, Kidney international.
[13] P S Heeger,et al. Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation‐05 Study , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] H. Ross,et al. Outcomes in adult congenital heart disease patients undergoing heart transplantation: A systematic review and meta-analysis. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[15] Jessica L. Howard,et al. Combined heart and liver transplantation can be safely performed with excellent short- and long-term results. , 2014, The Annals of thoracic surgery.
[16] M. Stegall,et al. Antibody‐mediated rejection in liver transplantation: Current controversies and future directions , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[17] A. Angelini,et al. The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[18] F. Fallani,et al. Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies , 2013, Journal of transplantation.
[19] R. Rodeheffer,et al. Combined Heart and Liver Transplant Attenuates Cardiac Allograft Vasculopathy Compared with Isolated Heart Transplantation , 2013, Transplantation.
[20] J. Heimbach,et al. Combined heart and liver transplantation: protection of the cardiac graft from antibody rejection by initial liver implantation. , 2013, Transplantation.
[21] K. Kokko,et al. Donor‐Directed MHC Class I Antibody Is Preferentially Cleared from Sensitized Recipients of Combined Liver/Kidney Transplants , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[22] E. Reed,et al. The long‐term outcome of treated sensitized patients who undergo heart transplantation , 2011, Clinical transplantation.
[23] Clive Lewis,et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[24] W. Kremers,et al. Combined Heart and Liver Transplantation: A Single-Center Experience , 2009, Transplantation.
[25] M. Oz,et al. The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database. , 2007, The Journal of thoracic and cardiovascular surgery.
[26] L. Mjörnstedt,et al. Successful Combined Partial Auxiliary Liver and Kidney Transplantation in Highly Sensitized Cross‐Match Positive Recipients , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[27] M. Stegall,et al. A Comparison of Plasmapheresis Versus High‐Dose IVIG Desensitization in Renal Allograft Recipients with High Levels of Donor Specific Alloantibody , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[28] S. Dunlap,et al. The Presence of HLA-Directed Antibodies after Heart Transplantation Is Associated with Poor Allograft Outcome , 2005, Transplantation.
[29] J. Narula,et al. Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry. , 1997, Transplantation.
[30] C. Delaney,et al. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. , 1995, Transplantation.
[31] R. Calne,et al. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. , 1995, Transplantation.
[32] T. Starzl,et al. Microchimerism, dendritic cell progenitors and transplantation tolerance , 1995, Stem cells.
[33] P. Gane,et al. Specific absorption of lymphocytotoxic alloantibodies by the liver in inbred rats. , 1990, Transplantation.
[34] B. Roser,et al. Reversal of transplantation immunity by liver grafting , 1981, Nature.